EDAP - EDAP TMS S.A.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.2200
-0.1600 (-6.72%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close2.3800
Open2.3100
Bid2.16 x 1800
Ask3.23 x 3200
Day's Range2.2200 - 2.3605
52 Week Range2.0700 - 4.2500
Volume108,701
Avg. Volume40,004
Market Cap64.375M
Beta (3Y Monthly)1.03
PE Ratio (TTM)N/A
EPS (TTM)-0.06
Earnings DateNov 13, 2018 - Nov 19, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.55
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    EDAP TMS SA : EDAP Announces Expiration of Second and Final Tranche of Outstanding Warrants

    EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today that warrants for 1.5 million ordinary shares in the form of American Depository Shares (ADSs) expired on November 29, 2018.

  • GlobeNewswire26 days ago

    EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference

    LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper.

  • GlobeNewswirelast month

    EDAP TMS SA : EDAP Reports 2018 Third Quarter Results

    Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea.

  • GlobeNewswirelast month

    EDAP TMS SA : EDAP TMS SA to Announce Third Quarter 2018 Financial Results on Wednesday, November 14

    LYON, France, November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the.

  • GlobeNewswire2 months ago

    EDAP TMS SA : Urologic Oncologists from Top US Teaching Hospitals Gather in Montreal to Learn Advanced Prostate Sparing Medical Procedure

    OCTOBER 24, 2018 - Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day - October 25, 2018 -- at Jewish General Hospital, a McGill University teaching hospital, where they will learn to perform a more precise outpatient prostate procedure called high intensity focused ultrasound (HIFU).  HIFU makes it possible to ablate diseased prostate tissue without the need to remove the prostate or damage critical structures that help control urinary and sexual function. The doctors will assist in performing HIFU on three different patients, using Focal One, the next generation HIFU system which received FDA clearance in the U.S. in June 2018.  Focal One fuses MRI and biopsy data with real-time ultrasound imaging.

  • Simply Wall St.2 months ago

    How Financially Strong Is EDAP TMS SA (NASDAQ:EDAP)?

    While small-cap stocks, such as EDAP TMS SA (NASDAQ:EDAP) with its market cap of US$78m, are popular for their explosive growth, investors should also be aware of their balance sheet Read More...

  • GlobeNewswire2 months ago

    EDAP TMS SA : EDAP Announces Expiration of Tranche of Outstanding Warrants

    EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today that warrants for approximately 3.3 million ordinary shares in the form of American Depository Shares (ADSs) expired on October 14, 2018. On April 14, 2016, pursuant to a securities purchase agreement dated April 7, 2016, the Company issued 3,283,284 ordinary shares in the form of ADSs to certain institutional investors in a registered direct placement, at a price of $3.50 per share, with warrants attached that allow investors to purchase up to 3,283,284 shares in the form of ADSs, at an exercise price of $4.50 per share.

  • GlobeNewswire3 months ago

    EDAP TMS SA : EDAP Announces the Installation of a Third Focal One® HIFU Device in Brazil

    The Albert Einstein Hospital, as a reference cancer center, sought this technology in order to offer its patients an individualized approach, making available all the possibilities of treatment of localized prostate cancer, with the objective of achieving the best possible outcomes according to the characteristics of the patient and tumor.

  • GlobeNewswire3 months ago

    EDAP TMS SA : Houston Methodist Medical Center Research Study Sheds Positive Light on Use of HIFU for Localized Prostate Cancer

    LYON, France, September 26, 2018 - EDAP TMS (EDAP) today announced the results of a study conducted at Houston Methodist Medical Center in Houston, TX that showed High Intensity Focused Ultrasound (HIFU) to be safe and effective, with oncologic control for prostate cancer patients. The study will be formally presented at a sectional meeting of the American Urological Association in Nashville, TN on September 26, 2018. Researchers evaluated the clinical outcomes from July 2016 to July 2018 on 24 patients who had a whole-gland HIFU procedure using the EDAP Ablatherm Robotic HIFU machine.

  • GlobeNewswire3 months ago

    EDAP TMS SA : EDAP announces Installation of First Focal One HIFU device in South Korea

    EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced the installation of the first Focal One device in South Korea, at the renowned Seoul National University Bundang Hospital ("SNUBH"). Dr. Hakmin Lee, Urologist in SNUBH commented: "We are very happy to adopt the first "Focal One" device in our institution and we also believe that Korean patients will significantly benefit from the upcoming HIFU procedures. From our initial experiences, the Focal One device showed extraordinary performance which was definitely beyond our expectations.

  • ACCESSWIRE4 months ago

    EDAP TMS SA Sponsored ADR to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 30, 2018 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 30, 2018 at 8:30 AM Eastern ...

  • ACCESSWIRE5 months ago

    Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks

    WallStEquities.com revisits the Medical Appliances and Equipment space, which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Under evaluation this morning are these four stocks: EDAP TMS S.A. (NASDAQ: EDAP), PAVmed Inc. (NASDAQ: PAVM), Amedica Corp. (NASDAQ: AMDA), and Avinger Inc. (NASDAQ: AVGR).

  • ACCESSWIRE6 months ago

    Wired News – RTI Surgical Commercially Launches Fortilink(R)-TS and -L IBF Systems with TETRAfuse 3D Technology

    LONDON, UK / ACCESSWIRE / June 14, 2018 / If you want access to our free research report on RTI Surgical, Inc. (NASDAQ: RTIX), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=RTIX as the Company's latest news hit the wire. On June 12, 2018, the Company announced that it has commercially launched Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology. The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures at one or two adjoining levels in patients with degenerative disc disease.

  • ACCESSWIRE6 months ago

    Major Regulatory Changes & Recent FDA Win Could Create a 400%+ Gain For Investors Holding This Unknown Stock

    Remote patient monitoring, through smaller cheaper technology, is transforming medical care in the U.S. Cardiac care is a major beneficiary, and now major government agencies are signalling that this sector could be a top priority in the coming years. New medical device from Biotricity (BTCY) could shake up a handful of existing companies in cardiac remote monitoring, as their new device has some clear improvements over older technology. With revenue and new product announcements this year, BTCY could move significantly higher in 2018 and 2019.

  • Reuters6 months ago

    US STOCKS-iPhone worries weigh on Wall Street

    U.S. stock indexes were lower on Friday as shares of Apple and its suppliers fell, following a report that the iPhone maker was planning to produce fewer phones this year. Apple Inc was down 1.6 percent after a newspaper report said the company had asked its supply chain to manufacture about 20 percent fewer components for iPhones in the latter half of 2018. Investors were also cautious ahead of a contentious G7 summit in Canada, with U.S. President Donald Trump lashing out at Canada and the European Union on Friday, raising the specter of a trade war.

  • Benzinga6 months ago

    Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Stocks hitting 52-week highs on June 7) Baxter International Inc (NYSE: BAX ) Bio-Rad Laboratories, ...

  • Benzinga6 months ago

    Benzinga Pro's 6 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Docusign Inc (NASDAQ: DOCU ) stock was trading higher ...

  • Was EDAP TMS SA.’s (NASDAQ:EDAP) Earnings Decline Part Of A Broader Industry Downturn?
    Simply Wall St.7 months ago

    Was EDAP TMS SA.’s (NASDAQ:EDAP) Earnings Decline Part Of A Broader Industry Downturn?

    When EDAP TMS SA. (NASDAQ:EDAP) announced its most recent earnings (31 December 2017), I did two things: looked at its past earnings track record, then look at what is happeningRead More...

  • ACCESSWIRE7 months ago

    EDAP TMS SA Sponsored ADR to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 15, 2018 / EDAP TMS SA Sponsored ADR (NASDAQ: EDAP ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 15, 2018 at 8:30 AM Eastern Time. ...